Current Therapeutic Approaches in FSHD

por Wang, Leo H., Tawil, Rabi
Publicado 2021

Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report

por Wang, Leo H., Johnstone, Laura M., Bindschadler, Michael, Tapscott, Stephen J., Friedman, Seth D.
Publicado 2021

Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy

por Wang, Leo H., Shaw, Dennis W. W., Faino, Anna, Budech, Christopher B., Lewis, Leann M., Statland, Jeffrey, Eichinger, Katy, Tapscott, Stephen J., Tawil, Rabi N., Friedman, Seth D.
Publicado 2021

Clinical utility of anti‐cytosolic 5’‐nucleotidase 1A antibody in idiopathic inflammatory myopathies

por Ikenaga, Chiseko, Findlay, Andrew R., Goyal, Namita A., Robinson, Sarah, Cauchi, Jonathan, Hussain, Yessar, Wang, Leo H., Kershen, Joshua C., Beson, Brent A., Wallendorf, Michael, Bucelli, Robert C., Mozaffar, Tahseen, Pestronk, Alan, Weihl, Conrad C.
Publicado 2021